May 27, 2017 4:11 PM ET

Pharmaceuticals

Company Overview of Octamer Inc.

Company Overview

Octamer Inc. develops pharmaceuticals for AIDS virus and cancer cells to prevent replication. Octamer's rational drug design takes advantage of the tremendous growth in understanding of gene expression regulatory systems that has occurred during the past 20 years. Octamer Inc. was founded in 1990 and is based in Tiburon, California.

392 Cecilia Way

Tiburon, CA 94920

United States

Founded in 1990

Phone:

415-518-8800

Fax:

415-388-6646

Key Executives for Octamer Inc.

Chairman and Chief Executive Officer
Chief Scientific Officer
Compensation as of Fiscal Year 2016.

Similar Private Companies By Industry

Company Name Region
1st Order Pharmaceuticals, Inc. United States
21st Century Animal Health United States
3 Buds' Organics LLC United States
4P Therapeutics LLC United States
60° Pharmaceuticals, LLC United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
The Advertising Council, Inc. United States
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Octamer Inc., please visit www.octamer.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.